Our fourth Changing Faces round-up is one that we don’t always publish, but in May and June we heard about enough hires in the public sector, non-profit, and academic worlds to stand in the
Gilead Sciences' chief medical officer, Merdad Parsey, will leave the company in early 2025, becoming the latest in a series of high-profile departures involving senior R&D figures at t
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.